Brain's prefrontal lobe is major player in Parkinson's Gait

August 10, 2016, Tel Aviv University

A new study by Tel Aviv University researchers demonstrates that the prefrontal cortex, the part of the brain associated with cognitive functions, plays a major role in "Parkinson's Gait." It suggests a radically new understanding of the mechanism underlying gait difficulties in people with Parkinson's disease (PD) and may lead to new therapeutic approaches.

The study was led by Prof. Jeffery Hausdorff of TAU's Sackler School of Medicine and Dr. Anat Mirelman of the Department of Neurology at TAU's Sackler School of Medicine, co-directors of the Center for the Study of Movement, Cognition and Mobility at the Tel Aviv Medical Center; and conducted in large part by Dr. Inbal Maidan of Tel Aviv Medical Center. The work was recently published in the journals Parkinsonism and Related Disorders and Neurorehabilitation and Neural Repair.

More than motor deficits involved

The ability to walk safely and independently is central to functional independence and quality of life. That ability is impaired in people with PD, rendering the most basic and commonplace tasks nearly impossible.

Researchers had previously theorized that motor deficits associated with PD were the direct cause of impaired walking, the reduced ability to multitask while walking, and the dangerous falls associated with the disease.

However, when TAU researchers asked patients to walk and complete another task—e.g., a verbal fluency task such as naming fruits or simple serial subtractions—at the same time, also called "dual tasking," the gait pattern of patients with PD became worse. They walked slower and with less stability. This suggested that cognitive resources were being used as they walked.

"Work by our group has demonstrated that cognitive control deficits play an active role in the walking difficulties experienced by many people with Parkinson's," said Prof. Hausdorff.

New pictures of the problem

The team used functional near infrared spectroscopy (fNIRS) to show that cognitive resources are utilized by PD patients much more often than by healthy individuals. "The advantage of fNIRS is that we can measure brain activation during actual walking," said Dr. Mirelman. "These results are consistent with our study using MRI that found brain activity in Parkinson's patients was activated in the even during 'imagined walking.'

"The overactivation of the prefrontal cortex has a two-pronged effect in Parkinson's patients," Dr. Mirelman continued. "Because the prefrontal cortex is 'saturated,' it is unable to perform other tasks, impairing gait and creating cognitive deficits. The debilitation is two-fold."

Even when patients were lying flat in the MRI and merely imagining themselves walking, there was a "ceiling effect"—they were unable to recruit additional cognitive resources to tackle more difficult tasks involved with walking. "The increased activation during normal walking curtails the ability of Parkinson's patients to recruit further cognitive resources during other challenging tasks," said Prof. Hausdorff. "It may even exacerbate the high risk of falling in these patients."

The team is now conducting research to better understand the underlying mechanisms of the brain activation pattern and therapeutic approaches that may improve gait and reduce the risk of falls. The information is critical to the design of appropriate therapies such as virtual reality or non-invasive brain stimulation to improve neural efficiency.

Explore further: Smartphone app may prevent dangerous freezing of gait in Parkinson's patients

Related Stories

Smartphone app may prevent dangerous freezing of gait in Parkinson's patients

June 25, 2015
Many patients in the latter stage of Parkinson's disease are at high risk of dangerous, sometimes fatal, falls. One major reason is the disabling symptom referred to as Freezing of Gait (FoG)—brief episodes of an inability ...

New brain imaging technology offers new approach for studying Parkinsonian syndromes

December 18, 2015
Using a portable device developed at Drexel University, researchers at Albert Einstein College of Medicine have identified differences in brain activation patterns associated with postural stability in people with Parkinsonian ...

Impaired decision-making may contribute to motor symptoms in Parkinson's disease

June 16, 2016
UCLA researchers have discovered that people with Parkinson's disease have a form of impaired decision-making that may be a major contributor to the movement problems that characterize the disease. The finding suggests that ...

Tokyo Tech researchers develop the WalkMate System for improving the quality of life of Parkinson's disease patients

August 28, 2012
Tokyo Tech's Yoshihiro Miyake and colleagues have developed an innovative, non-invasive therapeutic intervention that may improve the mobility, stability, and quality of life of Parkinson's disease patients.

New explanation for cognitive problems of Parkinson's patients

November 28, 2012
The hallmark of Parkinson's Disease is the uncertain gait and movement caused by the destructions of neurons producing the neurotransmitter dopamine.

Recommended for you

Half of those on Parkinson's drugs may develop impulse control problems

June 20, 2018
Over time, half of the people taking certain drugs for Parkinson's disease may develop impulse control disorders such as compulsive gambling, shopping or eating, according to a study published in the June 20, 2018, online ...

New evidence sheds light on how Parkinson's disease may happen

June 14, 2018
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

Scientists unravel molecular mechanisms of Parkinson's disease

June 12, 2018
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.

First photoactive drug to fight Parkinson's disease

June 8, 2018
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Researchers address sleep problems in Parkinson's disease

June 7, 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also ...

Drugs that suppress immune system may protect against Parkinson's

May 31, 2018
People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.